Corcept Therapeutics Inc
XBER:HTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Corcept Therapeutics Inc
XBER:HTD
|
US |
|
N
|
National Retail Properties Inc
F:CZ2
|
US |
|
V
|
Verbund AG
DUS:OEWA
|
AT |
|
Hermes International SCA
F:HMIA
|
FR |
|
T
|
TomCo Energy PLC
OTC:TMCGF
|
UK |
|
A
|
Akamai Technologies Inc
XMUN:AK3
|
US |
|
L
|
LEG Immobilien SE
SWB:LEG
|
DE |
|
S
|
Swiss Re AG
XETRA:SR9
|
CH |
|
Lattice Semiconductor Corp
NASDAQ:LSCC
|
US |
|
M
|
Motorola Solutions Inc
XBER:MTLA
|
US |
|
T
|
TX Group AG
SIX:TXGN
|
CH |
|
L
|
Lowe's Companies Inc
DUS:LWE
|
US |
|
Qrf NV
XBRU:QRF
|
BE |
|
H
|
Headwater Exploration Inc
OTC:CDDRF
|
CA |
|
Medicover AB
OTC:MCVEY
|
SE |
|
A
|
ASM International NV
XMUN:AVS
|
NL |
|
N
|
Nine Dragons Paper (Holdings) Ltd
XMUN:N3Y
|
HK |
|
C
|
CoStar Group Inc
XMUN:RLG
|
US |
|
O
|
Oxford Industries Inc
XBER:OXD
|
US |
|
L
|
Lagardere SA
DUS:LAG
|
FR |
|
E
|
Epizyme Inc
F:EPE
|
US |
|
IG Design Group PLC
F:LYG
|
UK |
Bankruptcy Probability
Corcept Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Corcept Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Corcept Therapeutics Inc
NASDAQ:CORT
|
5.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
919.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
535.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
207B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
277.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
216.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
148.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Corcept Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Corcept Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
